Sumitomo Pharma America, Inc.
- Country
- ๐บ๐ธUnited States
- Ownership
- Subsidiary
- Established
- 1984-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.sunovion.com
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
- First Posted Date
- 2009-03-25
- Last Posted Date
- 2016-04-14
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 817
- Registration Number
- NCT00868959
- Locations
- ๐บ๐ธ
Clinical Innovations Inc., Santa Ana, California, United States
๐บ๐ธAccurate Clinical Trials, Kissimmee, Florida, United States
๐บ๐ธSheppard Pratt Health System, Baltimore, Maryland, United States
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)
- First Posted Date
- 2009-03-25
- Last Posted Date
- 2014-04-17
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 505
- Registration Number
- NCT00868699
- Locations
- ๐บ๐ธ
CRI Worldwide, LLC, Philadelphia, Pennsylvania, United States
๐บ๐ธMood Disorders Program-UHCMC, Cleveland, Ohio, United States
๐ฎ๐ณR.K. Yadav Memorial Mental Health & De-Addiction Hospital, Jaipur, Rajasthan, India
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
- Conditions
- Interventions
- First Posted Date
- 2009-03-25
- Last Posted Date
- 2014-04-17
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 348
- Registration Number
- NCT00868452
- Locations
- ๐จ๐ฟ
Clintrial, s.r.o., Praha, Czech Republic
๐ฎ๐ณManobal Med. Research Centre, Lucknow, Uttar Prad, India
๐ท๐ดSpitalul Clinic Judetean de Urgenta Cluj, Cluj-Napoca, Romania
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
- Conditions
- Interventions
- First Posted Date
- 2009-03-20
- Last Posted Date
- 2016-03-11
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 193
- Registration Number
- NCT00866775
- Locations
- ๐บ๐ธ
Faculty of Physicians & Surgeons of Loma Linda University, Loma Linda, California, United States
๐บ๐ธInstitute of Neurology and Neurosurgery at St. Bamabas, Suite 101, Livingston, New Jersey, United States
๐บ๐ธMassachusetts General Hospital Epilepsy Service - WACC, Boston, Massachusetts, United States
Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia
- Conditions
- Interventions
- First Posted Date
- 2009-03-06
- Last Posted Date
- 2013-06-17
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 486
- Registration Number
- NCT00856973
- Locations
- ๐บ๐ธ
Tulsa Clinical Research, Tulsa, Oklahoma, United States
๐บ๐ธSomnoMedics, LLC, Tampa, Florida, United States
๐บ๐ธPediatric Epilepsy and Neurology Specialists, Tampa, Florida, United States
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
- Conditions
- Interventions
- First Posted Date
- 2009-03-06
- Last Posted Date
- 2017-10-26
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 304
- Registration Number
- NCT00857220
- Locations
- ๐บ๐ธ
Clinical Research Center of Nevada, Henderson, Nevada, United States
๐บ๐ธDavis Clinic, Indianapolis, Indiana, United States
๐บ๐ธGoldpoint Clinical Research, LLC, Indianapolis, Indiana, United States
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
- Conditions
- Interventions
- First Posted Date
- 2008-12-17
- Last Posted Date
- 2014-07-28
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 197
- Registration Number
- NCT00809757
- Locations
- ๐บ๐ธ
Dayton Clinical Research, Dayton, Ohio, United States
๐บ๐ธADAC Research, PA, Greenville, South Carolina, United States
๐บ๐ธSneeze, Wheeze & Itch Associates LLC, Normal, Illinois, United States
Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.
- Conditions
- Interventions
- First Posted Date
- 2008-11-13
- Last Posted Date
- 2016-03-17
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 488
- Registration Number
- NCT00790192
- Locations
- ๐บ๐ธ
CNRI-Los Angeles. LLC, Pico Rivera, California, United States
๐บ๐ธFlorida Clinical Research Center, Bradenton, Florida, United States
๐ท๐ดSpitalul de Psihiatrie Titan "Dr. Constantin Gorgos", Bdul Nicolae Grigorescu nr. 41, Bucuresti, Romania
Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia
- First Posted Date
- 2008-11-13
- Last Posted Date
- 2015-06-12
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 240
- Registration Number
- NCT00789698
- Locations
- ๐บ๐ธ
Florida Clinical Research Center LLC, Bradenton, Florida, United States
๐บ๐ธPillar Clinical Research, Dallas, Texas, United States
๐ฎ๐ณDeenanath Mangeshkar Hospital and Research Centre, Pune, Maharastra, India
Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis
- Conditions
- Interventions
- First Posted Date
- 2008-11-13
- Last Posted Date
- 2016-04-08
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 707
- Registration Number
- NCT00790023